WCM
BVS icon

Wedge Capital Management’s Bioventus BVS Stock Holding History

Wedge Capital Management’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.03M Sell
215,051
-26,775
-11% -$256K 0.03% 335
2026
Q1 		$2.21M Buy
+241,826
New +$2.03M 0.04% 328

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wedge Capital Management's BVS Position: Q2 2026 in Review

Wedge Capital Management reduced its Bioventus (BVS) stake by 11% in Q2 2026, selling an estimated $256K and leaving 215,051 shares worth $2.03M. The position accounts for 0.03% of the portfolio, ranked #335.

Wedge Capital Management first reported a position in BVS in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.21M in Q1 2026. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Wedge Capital Management held 215,051 shares of Bioventus worth $2.03M as of Q2 2026.
  • Wedge Capital Management sold 26,775 Bioventus shares in Q2 2026, an estimated $256K.
  • Bioventus made up 0.03% of Wedge Capital Management's portfolio in Q2 2026, its #335 holding.
  • Wedge Capital Management first reported a position in Bioventus in Q1 2026 and has held it in 2 quarters since.
  • Wedge Capital Management's Bioventus position peaked at $2.21M in Q1 2026.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Wedge Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.